×
Top
Bottom

Snap Stock Soars as Q2 Earnings Face “Low Bar” Expectations

Snap Stock Rallies Ahead of Q2 2025 Earnings on Optimism Over “Low Bar” Estimates

Analyst Expectations Set Stage for Snap to Outperform in Quarterly Results

Snap Inc. (SNAP) shares surged on Friday as investors anticipated the company’s Q2 2025 earnings report, scheduled for release on Monday.

  • Edgewater Research analysts highlighted that Wall Street’s expectations are modest, describing them as a “low bar” for Snap to surpass in this quarter’s results.

Wall Street currently projects average revenue of $1.343 billion for Q2, a figure that Edgewater Research believes is too conservative.

  • The firm provided its own higher estimate, setting the bar at $1.362 billion.
  • Ongoing momentum in Direct Response advertising was noted as a driver for growth, although broader macroeconomic factors continue to limit further gains.

Earnings Performance and Investor Response

Wall Street also anticipates that Snap will report adjusted earnings per share (EPS) of -16 cents in Q2 2025.

  • Snap has a strong track record, having beaten analysts’ EPS estimates for eight consecutive quarters.

Investor enthusiasm was evident as Snap stock climbed 6.76% on Friday morning, signaling confidence ahead of earnings.

  • Despite this rally, SNAP shares remain down 19.31% year-to-date and have fallen 50.99% over the past 12 months.
  • Trading volume spiked, with 26.94 million shares traded early in the day compared to a three-month daily average of roughly 28 million shares.

Wall Street’s Outlook: Hold Recommendation

The consensus among Wall Street analysts is to Hold Snap stock.

  • The average price target of $9.68 implies an 11.07% potential upside from current levels.
  • This cautious outlook reflects ongoing uncertainty despite short-term trading momentum.
Share this article
Shareable URL
Prev Post

Economic Uncertainty Rises: Canada Faces GDP Contraction and Recession Fears

Next Post

Analyst Turns Bullish on GOOGL as AI Boosts User Engagement

Read next
0
Share